Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Review of. cap alpha. /. beta. ratios for experimental tumors: implications for clinical studies of altered fractionation

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Clinical interest in the use of more and smaller dose fractions in radical radiotherapy has been stimulated by recent reviews of experimental results with normal tissues. It has been found that if the dose per fraction is reduced (i.e., in hyperfractionation) there is sparing of late responding normal tissues relative to those which respond early. This phenomenon can be understood in terms of the shapes of the underlying dose effect relationships, which can be described using the linear quadratic equation. The ratio (..cap alpha../..beta..) of the linear (..cap alpha..) and quadratic (..beta..) terms is a useful measure of the curviness of such dose effect curves. The authors have reviewed published results for experimental tumors irradiated in situ and either assayed in situ or after excision. The ..cap alpha../..beta.. ratios were usually at least as high as those for acutely responding normal tissues, and 36/48 tumors gave values > 8 Gy. Low values of less than 5 Gy were obtained for only 4/48 tumors. There are considerable technical problems in interpreting these experiments, but the results do suggest that hyperfractionation might confer therapeutic gain relative to late responding normal tissues on the basis of differences in repair capability. In clinical practice more efficient reoxygenation, cell cycle redistribution and decreased overall treatment time might also confer therapeutic gain.
Research Organization:
Mount Vernon Hospital, Northwood, England
OSTI ID:
5751664
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 11:1; ISSN IOBPD
Country of Publication:
United States
Language:
English